In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer

Theranostics

Volumn 2, Issue 7, 2012, Pages 714-722

  Kumar, Rajiv ^a   Kulkarni, Apurva ^a   Nagesha, Dattatri K ^a   Sridhar, Srinivas ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cancer; Drug delivery; Imaging; Theranostic polymeric micelles

Indexed keywords

DOXORUBICIN; DRUG CARRIER; POLYMER; QUANTUM DOT; THERANOSTIC POLYMERIC MICELLE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; FEMALE; FLUORESCENCE IMAGING; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEOPLASM; SPECTROSCOPY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84864417613     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3927     Document Type: Article

References (35)

1. Wagner V, Dullaart A, Bock A. The emerging nanomedicine landscape. Nat Biotechnol. 2006; 24: 1211-8
2. Lim WT, Tan EH, Toh CK, et al. Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. Ann Oncol 2009; 21: 382-8.
3. Davis ME, Zuckerman JE, Choi CHJ, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 2010; 464: 1067-0.
4. Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomedicine. 2008; 3: 137-0.
5. Zhang L, Gu F, Chan J, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2007; 83: 761-9.
6. Papadopoulos N, Kinzler KW, Vogelstein B. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies. Nat Biotechnol. 2006; 24: 985-5.
7. Liong M, Lu J, Kovochich M, Xia T, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008; 2: 889-6.
8. Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 2004; 22: 93-7.
9. Nyk M, Kumar R, Ohulchanskyy TY, et al. High Contrast in vitro and in vivo photoluminescence bioimaging using near infrared to near infrared up-conversion in Tm3+ and Yb3+ doped fluoride nanophosphors. Nano Lett. 2008; 8: 3834-8.
10. Deissler V, Ruger R, Frank W, et al. Fluorescent liposomes as contrast agents for in vivo optical imaging of edemas in mice. Small. 2008; 4: 1240-6.
11. Josephson L, Kircher MF, Mahmood U, et al. Near-infrared fluorescent nanoparticles as combined MR/Optical imaging probes. Bioconjugate Chem. 2002; 13: 554-0.
12. He X, Nie H, Wang K, et al. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem. 2008; 80: 9597-3.
13. Kumar R, Ohulchanskyy TY, Roy I, et al. Near-infrared phosphorescent polymeric nanomicelles: efficient optical probes for tumor imaging and detection. ACS Appl Mater Interfaces. 2009; 1: 1474-1.
14. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007; 24: 1-16.
15. Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm. 2010; 7:1959-73.
16. Krishnadas A, Rubinstein I, Önyüksel H. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res. 2003; 20: 297-2.
17. Vakil R, Kwon GS. Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles. Mol Pharm. 2008; 5: 98-4.
18. Lukyanov AN, Gao ZG, Mazzola L, et al. Polyethylene glycoldiacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res. 2002; 19: 1424-9.
19. Yong KT, Roy I, Law WC, et al. Synthesis of cRGD-peptide conjugated near-infrared CdTe/ZnSe core-shell quantum dots for in vivo cancer targeting and imaging. Chem Comm. 2010; 46: 7136-8.
20. Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: a new frontier in cancer chemotherapy. J Chemother. 2004; 16: 94-7.
21. Frederick CA, Williams LD, Ughetto G, et al. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Bio-chemistry. 1990; 29: 2538-9.
22. Fornari FA, Randolph JK, Yalowich JC, et al. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol. 1994; 45: 649-6.
23. Cummings J, Smyth JF. DNA topoisomerase I and II as targets for rational design of new anticancer drugs. Ann Oncol. 1993; 4: 533-3.
24. Farokhzad OC, Zhang L, Kantoff P, et al. Quantum dotaptamer conju-gates for synchronous cancer imaging, therapy, and sensing of drug de-livery based on bi-flourescence resonance energy transfer. Nano Letters. 2007; 7: 3065-0.
25. Chakravarthy KV, Davidson BA, Helinski JD, et al. Doxorubicinconjugated quantum dots to target alveolar macrophages and in-flammation. Nanomedicine: Nanotechnology, Biology and Medicine. 2011; 7: 88-6.
26. Kim D, Gao ZG, Lee ES, et al. In vivo evaluation of doxorubicinloaded polymeric micelles targeting folate receptors and early endosomal pH in drugresistant ovarian cancer. Mol Pharma. 2009; 6: 1353-2.
27. Patil RR, Guhagarkar SA, Devarajan PV. Engineered nanocarriers of doxorubicin: a current update. Crit Rev Ther Drug Carrier Syst. 2008; 25: 1-61.
28. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst 2003; 20: 357-03.
29. Dubertret B, Skourides P, Norris DJ, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002; 298:1759-2.
30. Carion O, Mahler B, Pons T, et al. Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nat Protocols 2007; 2: 2383-0.
31. Park JH, Maltzahn G, Ruoslahti E, et al. Micellar Hybrid Nanoparticles for Simultaneous Magneto-Fluorescent Imaging and Drug Delivery. Angew Chem Int Ed. 2008; 47: 7284-8.
32. Ni T, Nagesha DK, Robles J, et al. CdS nanoparticles modified to chalcogen sites: new supramolecular complexes, butterfly bridging, and related optical effects. J Am Chem Soc. 2002; 124: 3980-2.
33. Baker DR, Kamat PV. Tuning the emission of CdSe quantum dots by controlled trap enhancement. Langmuir. 2010; 26: 11272-6.
34. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, et al. (CdSe)ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem B. 1997; 101: 9463-5.
35. Kumar R, Roy I, Ohulchanskyy TY, et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2008; 2: 449-6.